1830:TADAWULLeejam Sports Company Analysis
Data as of 2026-03-17 - not real-time
SAR 82.20
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Leejam Sports is trading at SAR 82.2, well below its 20‑day SMA of 84.5 and far beneath the 50‑day (93.1) and 200‑day (121.9) moving averages, signaling a bearish price environment. The RSI sits at 39.9, approaching oversold territory, while the MACD line has crossed above its signal, offering a modest bullish hint but not enough to offset the broader downtrend. Volume is on a decreasing trajectory, and the 30‑day volatility of 39% combined with a very low beta (0.12) suggests price swings are pronounced yet not strongly correlated with the market. On the fundamentals side, the company delivers a solid dividend yield of 4.63% with a high payout ratio of 79%, but its debt‑to‑equity ratio of 169% and total debt of SAR 2.03 bn raise leverage concerns. Free cash flow remains positive at SAR 186.9 m, supporting the dividend for now, yet the DCF‑derived fair value of only SAR 18.7 implies the market price is dramatically overvalued. Analysts collectively rate the stock as a “buy,” but the upside/downside metric of 81.7% indicates limited upside potential and a substantial risk of correction.
Given the extreme greed sentiment (Fear‑Greed Index 79.45) and the lack of material news catalysts, the near‑term outlook is constrained by technical weakness and balance‑sheet strain, while the dividend may provide some cushion for longer horizons. Investors should weigh the attractive yield against the high leverage and the stark disparity between market price and intrinsic valuation before deciding on exposure.
Given the extreme greed sentiment (Fear‑Greed Index 79.45) and the lack of material news catalysts, the near‑term outlook is constrained by technical weakness and balance‑sheet strain, while the dividend may provide some cushion for longer horizons. Investors should weigh the attractive yield against the high leverage and the stark disparity between market price and intrinsic valuation before deciding on exposure.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price below all major moving averages
- High leverage with debt‑to‑equity > 160%
- Market price far exceeds DCF fair value
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Attractive dividend yield of 4.63%
- Positive free cash flow supporting payouts
- Persistently high volatility and decreasing volume
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- Potential recovery in consumer cyclical leisure spending
- Dividend income as a buffer against price weakness
- Long‑term valuation correction toward intrinsic value
Key Metrics & Analysis
Financial Health
Revenue Growth2.60%
Profit Margin18.88%
P/E Ratio12.8
ROE24.74%
ROA6.78%
Debt/Equity168.92
P/B Ratio3.6
Op. Cash FlowSAR772.9M
Free Cash FlowSAR187.0M
Technical Analysis
TrendBearish
RSI40.0
SupportSAR 75.70
ResistanceSAR 101.00
MA 20SAR 84.54
MA 50SAR 93.15
MA 200SAR 121.90
MACDBullish
VolumeDecreasing
Fear & Greed Index79.45
Valuation
Fair ValueSAR 18.66
Target PriceSAR 149.35
Upside/Downside81.69%
GradeOvervalued
TypeValue
Dividend Yield4.63%
Risk Assessment
Beta0.12
Volatility39.18%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.